Kevin Joseph Fitzgerald - 20 Mar 2024 Form 3 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
CSO & EVP, Head of Research
Signature
By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald
Issuer symbol
ALNY
Transactions as of
20 Mar 2024
Net transactions value
$0
Form type
3
Filing time
28 Mar 2024, 16:17:17 UTC
Previous filing
26 Feb 2024
Next filing
26 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALNY Common Stock 12,881 20 Mar 2024 Direct
holding ALNY Common Stock 537 20 Mar 2024 by Managed Account F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALNY Performance Stock Option 2017 (right to buy) 20 Mar 2024 Common Stock 9,000 $119.13 Direct
holding ALNY Stock Option (right to buy) 20 Mar 2024 Common Stock 16,250 $85.00 Direct F2
holding ALNY Stock Option (right to buy) 20 Mar 2024 Common Stock 6,667 $97.72 Direct F2
holding ALNY Stock Option (right to buy) 20 Mar 2024 Common Stock 14,580 $118.05 Direct F2
holding ALNY Stock Option (right to buy) 20 Mar 2024 Common Stock 9,000 $119.13 Direct F3
holding ALNY Stock Option (right to buy) 20 Mar 2024 Common Stock 20,382 $147.47 Direct F2
holding ALNY Stock Option (right to buy) 20 Mar 2024 Common Stock 15,692 $151.59 Direct F2
holding ALNY Stock Option (right to buy) 20 Mar 2024 Common Stock 9,279 $152.61 Direct F2
holding ALNY Stock Option (right to buy) 20 Mar 2024 Common Stock 10,352 $190.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
F2 The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.
F3 The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter over the following thirty-three (33) months of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney